{"id":24181,"date":"2021-02-22T13:37:47","date_gmt":"2021-02-22T12:37:47","guid":{"rendered":"https:\/\/staging.capitalmind.com\/deals\/sales-of-kammanneye-to-sanoptis\/"},"modified":"2021-03-22T15:59:28","modified_gmt":"2021-03-22T14:59:28","slug":"sales-of-kammanneye-to-sanoptis","status":"publish","type":"deals","link":"https:\/\/dev2.capitalmind.com\/fr\/deals\/sales-of-kammanneye-to-sanoptis\/","title":{"rendered":"Cession de KammannEye \u00e0 Sanoptis"},"content":{"rendered":"<h2>Contexte de l&rsquo;op\u00e9ration<\/h2>\n<p>Fond\u00e9 en 2000 par le Dr. Marc Kammann, KammannEye AG <span class=\"VIiyi\" lang=\"fr\"><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"fr\" data-language-to-translate-into=\"en\" data-phrase-index=\"0\">est l&rsquo;un des principaux fournisseurs de services d&rsquo;ophtalmologie et de chirurgie de l\u2019\u0153il dans le canton des Grisons, en Suisse.<\/span> <span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"fr\" data-language-to-translate-into=\"en\" data-phrase-index=\"1\">Apr\u00e8s une forte croissance ces derni\u00e8res ann\u00e9es et afin de poursuivre dans cette voie, l&rsquo;actionnaire a fait le choix de c\u00e9der l&rsquo;entreprise au groupe<\/span><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"fr\" data-language-to-translate-into=\"en\" data-phrase-index=\"2\"> Sanoptis.<\/span><\/span><\/p>\n<p><span class=\"VIiyi\" lang=\"fr\"><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"fr\" data-language-to-translate-into=\"en\" data-phrase-index=\"0\">Sanoptis est un groupe innovant de services d&rsquo;ophtalmologie dont le si\u00e8ge est bas\u00e9<\/span><span class=\"JLqJ4b ChMk0b\" data-language-for-alternatives=\"fr\" data-language-to-translate-into=\"en\" data-phrase-index=\"2\"> \u00e0 Pf\u00e4ffikon, en Suisse. Le groupe compte plus de 160 sites en Allemagne et en Suisse.<\/span><\/span><\/p>\n<h2>Notre r\u00f4le<\/h2>\n<p>Investec a conseill\u00e9 le fondateur actionnaire de KammannEye tout au long du process de cession: structuration de l&rsquo;op\u00e9ration, pr\u00e9paration de la documentation marketing, screening et s\u00e9lection des acqu\u00e9reurs potentiels, management des due diligence et des termes et conditions de l&rsquo;op\u00e9ration jusqu&rsquo;au closing.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Contexte de l&rsquo;op\u00e9ration Fond\u00e9 en 2000 par le Dr. Marc Kammann, KammannEye AG est l&rsquo;un des principaux fournisseurs de services&#8230;<\/p>\n","protected":false},"featured_media":0,"template":"","dt":[],"sector":[3768],"dealtype":[3706],"clienttype":[3729],"class_list":["post-24181","deals","type-deals","status-publish","hentry","sector-healthcare-fr","dealtype-cession-fr","clienttype-entrepreneurs-fr"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals\/24181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/types\/deals"}],"wp:attachment":[{"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/media?parent=24181"}],"wp:term":[{"taxonomy":"dt","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/dt?post=24181"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/sector?post=24181"},{"taxonomy":"dealtype","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/dealtype?post=24181"},{"taxonomy":"clienttype","embeddable":true,"href":"https:\/\/dev2.capitalmind.com\/fr\/wp-json\/wp\/v2\/clienttype?post=24181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}